Quick Links

Biden Administration Strengthens Insurance Requirements for COVID-19 Diagnostic Testing

Posted on: 3/2/2021

The following message was sent on February 26 from the Centers for Medicare and Medicaid Services:

In accordance with the Executive Order President Biden signed on January 21, 2021, the Centers for Medicare & Medicaid Services (CMS), together with the Department of Labor and the Department of the Treasury, (collectively, the Departments) issued new guidance today removing barriers to COVID-19 diagnostic testing and vaccinations and strengthening requirements that plans and issuers cover diagnostic testing without cost sharing.

This guidance makes clear that private group health plans and issuers generally cannot use medical screening criteria to deny coverage for COVID-19 diagnostic tests for individuals with health coverage who are asymptomatic, and who have no known or suspected exposure to COVID-19. Such testing must be covered without cost sharing, prior authorization, or other medical management requirements imposed by the plan or issuer. For example, covered individuals wanting to ensure they are COVID-19 negative prior to visiting a family member would be able to be tested without paying cost sharing. The guidance also includes information for providers on how to get reimbursed for COVID-19 diagnostic testing or for administering the COVID-19 vaccine to those who are uninsured.

This announcement clarifies the circumstances in which group health plans and issuers offering group or individual health insurance coverage must cover COVID-19 diagnostic tests without cost sharing, prior authorization, or other medical management requirements to include tests for asymptomatic individuals without known or suspected exposure to COVID-19. In addition, the guidance confirms that plans and issuers must cover point-of-care COVID-19 diagnostic tests, and COVID-19 diagnostic tests administered at state or locally administered testing sites.

The Departments have received many questions about plan and issuer responsibility to cover COVID-19 diagnostic testing for individuals who are asymptomatic and have no known or suspected recent exposure to COVID-19. Today’s guidance clarifies that plans and issuers generally must cover, with no cost sharing, COVID-19 diagnostic tests regardless of whether the patient is experiencing symptoms or has been exposed to COVID-19 when a licensed or authorized health care provider administers or has referred a patient for such a test. Additionally, plans and issuers are prohibited from requiring prior authorization or other medical management for COVID-19 diagnostic testing.

This guidance also reinforces existing policy regarding coverage for the administration of the COVID-19 vaccine and highlights avenues for providers to seek federal reimbursement for costs incurred when administering COVID-19 diagnostic testing or a COVID-19 vaccine to those who are uninsured. One such existing program is through the Provider Relief Fund program, which has a separate effort for providers to submit claims and seek reimbursement on a rolling basis for COVID-19 testing, COVID-19 treatment, and administering COVID-19 vaccines to uninsured individuals (the HRSA COVID-19 Uninsured Program). The HRSA Uninsured Program has already reimbursed providers more than $3 billion for the testing and treatment of uninsured individuals, and expects to see vaccine administration claims as states scale up their vaccination efforts. To further build awareness about the availability of this program, this announcement seeks comment on strategies to connect those without insurance to care from providers participating in this fund.

Through previous guidance and rulemaking, the Departments addressed coverage requirements for COVID-19 vaccines and diagnostic testing in an interim final rule and FAQs Part 42 and FAQs Part 44. Today’s announcement further expands upon and clarifies these policies. For more information on issuer and provider vaccine coverage and reimbursement requirements, the CMS toolkit is available here.

The guidance issued today can be viewed here: https://www.cms.gov/files/document/faqs-part-44.pdf

The Centers for Medicare and Medicaid Services and the ACMA Public Policy Committee contributed to this information.

Return to Legislative Postings

Save the Date | 2025 Leadership and Physician Advisor Conference

The 2025 Leadership and Physician Advisor Conference is November 12-14 in Boston, MA! Health plans and providers, this conference has everything you need.
Save the date!

SAVE THE DATE | ACMA 2026 National Conference

Join us for ACMA 2026 National Conference, April 20-23, 2026 in Orlando, FL. Don't miss out on the premier case management and transitions of care conference of the year!
Experience ACMA at National!

Share Your Research | Collaborative Case Management

Do you have a project or measurable initiative you've instituted at your organization? Have you conducted research on a current issue in the field? Share your experiences and results with your professional community! Email your proposal or questions: vmatthews@acmaweb.org.
Learn more!

Now Accepting Presentations for Chapter Conferences

We are now accepting presentations for upcoming ACMA chapter conferences. If you have a unique solution, intervention or strategy to improve case management, this is a great opportunity to share your knowledge and be a part of ACMA's national-caliber education at the local level. There is no deadline to submit; presentations will be accepted throughout the year so you can prepare a submission as your schedule allows.
Submit a presentation!

Care Transitions Today Podcast

Our upcoming series, Case by Case, is co-presented by the American Case Management Association (ACMA) and the Association of Physician Leadership in Care Management (APLCM). In the Case by Case series, we delve deep into real-world medical cases, sharing experiences, best practices, and innovative approaches to patient care. Led by returning experts Dr. Rebecca Severe and Dr. Sweta Singh, along with rotating guest panelists, our hosts bring you a new case study, offering a unique learning opportunity for health care professionals at all levels of experience. Learn more!

Get ACMA News in the Palm of Your Hand

Join the conversation with ACMA! Text the keyword ACMA to 844-554-2497 to stay up to date on all the latest news and announcements, delivered straight to your phone!

Karen Vanaskie Scholarship Fund

Karen Vanaskie was one of case management's brightest and most dedicated professionals. She was serving as Secretary / Treasurer on the ACMA National Board of Directors at the time of her unexpected passing on June 21, 2024.

At the request of Karen's family, ACMA has set up the Karen Vanaskie Scholarship Fund. Karen was passionate about the need for case management certification. She actively supported her staff in pursuing the Accredited Case Manager (ACM) Certification. To continue her legacy, this scholarship fund will cover the cost of their ACM certification application fee for those to whom it is awarded. We believe this continues Karen's legacy.

To apply for the scholarship, click here. For eligibility details, please see below.

To donate to the scholarship fund in Karen's memory, click here.

2024 National Survey Results are Live!

ACMA and APLCM are proud to announce the latest iterations of the National Case Management and Transitions of Care Survey and the Physician Leaders in Care Management Survey, which have been the only source of comprehensive data for the case management industry since 2001. This ongoing research incorporates over 20 years of data, offering invaluable insights into the evolving landscape of case management, transitions of care, and physician advising. Access the full reports through your ACMA and APLCM member portals!

SAVE THESE DATES | National Case Management Week

2025 - October 12-18
2026 - October 11-17
2027 - October 10-16
2028 - October 8-14